Vericiguat for the Treatment of Heart Failure with Reduced Ejection Fraction Following a Worsening Heart Failure Event: A Cost-Effectiveness Analysis from the Perspective of Chinese Healthcare Providers-Reference-Cited by-同舟云学术

Vericiguat for the Treatment of Heart Failure with Reduced Ejection Fraction Following a Worsening Heart Failure Event: A Cost-Effectiveness Analysis from the Perspective of Chinese Healthcare Providers

Published:2023-03-16 Issue:4 Volume:43 Page:241-250
ISSN:1173-2563
Container-title:Clinical Drug Investigation
language:en
Short-container-title:Clin Drug Investig

Author:

Yu Xiangyou,Hao Yan,Zhu Zhanfang,Zhang Wei,Liu Bo,Ma Meijuan,Zhang Xuejun,Wei Na,Wang Junkui,Liu Fuqiang

Funder

Science and Technology Program of Xi’an

Key Industry Innovation Chain of Shaanxi

the Shaanxi Provincial Health and Health Research Fund Project

Natural Science Foundation of Shaanxi Province

the Key Basic Natural Science Foundation of Shaanxi Province

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s40261-023-01253-y.pdf

Reference39 articles.

1. Murphy SP, Ibrahim NE, Januzzi JL. Heart failure with reduced ejection fraction: a review. JAMA. 2020;324(5):488–504. https://doi.org/10.1001/jama.2020.10262.

2. Hao G, Wang X, Chen Z, Zhang L, Zhang Y, Wei B, et al. Prevalence of heart failure and left ventricular dysfunction in China: the China Hypertension Survey, 2012–2015. Eur J Heart Fail. 2019;21(11):1329–37. https://doi.org/10.1002/ejhf.1629.

3. Dunlay SM, Roger VL, Redfield MM. Epidemiology of heart failure with preserved ejection fraction. Nat Rev Cardiol. 2017;14(10):591–602. https://doi.org/10.1038/nrcardio.2017.65.

4. Johansson I, Joseph P, Balasubramanian K, McMurray JJV, Lund LH, Ezekowitz JA, et al. Health-related quality of life and mortality in heart failure: the Global Congestive Heart Failure Study of 23 000 Patients from 40 countries. Circulation. 2021;143(22):2129–42. https://doi.org/10.1161/circulationaha.120.050850.

5. Koh AS, Tay WT, Teng THK, Vedin O, Benson L, Dahlstrom U, et al. A comprehensive population-based characterization of heart failure with mid-range ejection fraction. Eur J Heart Fail. 2017;19(12):1624–34. https://doi.org/10.1002/ejhf.945.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost–Utility Analysis of Vericiguat in Heart Failure with Reduced Ejection Fraction After Worsening Heart Failure Events in China;American Journal of Cardiovascular Drugs;2024-04-15